Design, Synthesis, and Evaluation of Triazole Derivatives That Induce Nrf2 Dependent Gene Products and Inhibit the Keap1-Nrf2 Protein-Protein Interaction

被引：93
|
作者：
Bertrand, Helene C. [1 ]
Schaap, Marjolein [1 ]
Baird, Liam [2 ]
Georgakopoulos, Nikolaos D. [1 ]
Fowkes, Adrian [1 ]
Thiollier, Clarisse [1 ]
Kachi, Hiroko [1 ]
Dinkova-Kostova, Albena T. [2 ,3 ,4 ]
Wells, Geoff [1 ]
机构：
[1] UCL, UCL Sch Pharm, London WC1N 1AX, England
[2] Univ Dundee, Med Res Inst, Div Canc Res, Jacqui Wood Canc Ctr, Dundee DD1 9SY, Scotland
[3] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[4] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 2015年 / 58卷 / 18期
基金：
英国生物技术与生命科学研究理事会;
关键词：
RANDOMIZED CLINICAL-TRIAL; OXIDATIVE STRESS; PEPTIDE INHIBITORS; NRF2-KEAP1; COMPLEX; KELCH DOMAIN; DLG MOTIFS; BINDING; PATHWAY; UBIQUITINATION; DISCOVERY;
D O I：
10.1021/acs.jmedchem.5b00602
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
The transcription factor Nrf2 regulates the expression of a large network of cytoprotective and metabolic enzymes and proteins. Compounds that directly and reversibly inhibit the interaction between Nrf2 and its main negative regulator Keap1 are potential pharmacological agents for a range of disease types including neurodegenerative conditions and cancer. We describe the development of a series of 1,4-dipheny1-1,2,3-triazole compounds that inhibit the Nrf2-Keap1 protein protein interaction (PPI) in vitro and in live cells and up-regulate the expression of Nrf2-dependent gene products.
引用
收藏
页码：7186 / 7194
页数：9
相关论文
共 50 条
  • [31] Direct inhibition of Keap1-Nrf2 Protein-Protein interaction as a potential therapeutic strategy for Alzheimer's disease
    Sun, Yi
    Huang, Jiaxuan
    Chen, Yufei
    Shang, Hao
    Zhang, Wannian
    Yu, Jianqiang
    He, Ling
    Xing, Chengguo
    Zhuang, Chunlin
    BIOORGANIC CHEMISTRY, 2020, 103
  • [32] Discovery of Potent Keap1-Nrf2 Protein-Protein Interaction Inhibitor Based on Molecular Binding Determinants Analysis
    Jiang, Zheng-Yu
    Lu, Meng-Chen
    Xu, Li-Li
    Yang, Ting-Ting
    Xi, Mei-Yang
    Xu, Xiao-Li
    Guo, Xiao-Ke
    Zhang, Xiao-Jin
    You, Qi-Dong
    Sun, Hao-Peng
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (06) : 2736 - 2745
  • [33] Discovery of Potent Keap1-Nrf2 Protein-Protein Interaction Inhibitor Based on Molecular Binding Determinants Analysis
    Jiang, Zheng-Yu
    Lu, Meng-Chen
    Xu, Li-Li
    Yang, Ting-Ting
    Xi, Mei-Yang
    Xu, Xiao-Li
    Guo, Xiao-Ke
    Zhang, Xiao-Jin
    You, Qi-Dong
    Sun, Hao-Peng
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (10) : 4406 - 4406
  • [34] A potent phosphodiester Keap1-Nrf2 protein-protein interaction inhibitor as the efficient treatment of Alzheimer's disease
    Sun, Yi
    Xu, Lijuan
    Zheng, Dongpeng
    Wang, Jue
    Liu, Guodong
    Mo, Zixin
    Liu, Chao
    Zhang, Wannian
    Yu, Jianqiang
    Xing, Chengguo
    He, Ling
    Zhuang, Chunlin
    REDOX BIOLOGY, 2023, 64
  • [35] Kidney Protection by a Novel Keap1-Nrf2 Protein-Protein Interaction Inhibitor for a Mouse Model of Alport Syndrome
    Horizono, Jun
    Kaseda, Shota
    Sannomiya, Yuya
    Suico, Mary Ann
    Fukiya, Hirohiko
    Sunamoto, Hidetoshi
    Watanabe, Hiroshi
    Nakano, Takehiro
    Tokumaru, Kai
    Davenport, John Bernard
    John, Bernard
    Shuto, Tsuyoshi
    Lennon, Rachel
    Onuma, Kazuhiro
    Kai, Hirofumi
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [36] A cell-active cyclic peptide targeting the Nrf2/Keap1 protein-protein interaction
    Iegre, Jessica
    Krajcovicova, Sona
    Gunnarsson, Anders
    Wissler, Lisa
    Kaeck, Helena
    Luchniak, Anna
    Tangefjord, Stefan
    Narjes, Frank
    Spring, David R.
    CHEMICAL SCIENCE, 2023, 14 (39) : 10800 - 10805
  • [37] In silico Evidence for Binding of Pentacyclic Triterpenoids to Keap1-Nrf2 Protein-Protein Binding Site
    Kamble, Sarika M.
    Patel, Harun M.
    Goyal, Sameer N.
    Noolvi, Malleshappa N.
    Mahajan, Umesh B.
    Ojha, Shreesh
    Patil, Chandragouda R.
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2017, 20 (03) : 215 - 234
  • [38] Structural investigation of Keap1-Nrf2 protein-protein interaction (PPI) inhibitors for treating myocarditis through molecular simulations
    Tuo, Yan
    Tang, Yuelu
    Yu, Yongxin
    Liang, Haoran
    Huang, Bin
    Geng, Shan
    Wang, Yuanqiang
    NEW JOURNAL OF CHEMISTRY, 2023, 47 (18) : 8524 - 8537
  • [39] Phenyl Bis-Sulfonamide Keap1-Nrf2 Protein-Protein InteractionInhibitors with an Alternative Binding Mode
    Georgakopoulos, Nikolaos
    Talapatra, Sandeep
    Dikovskaya, Dina
    Naidu, Sharadha Dayalan
    Higgins, Maureen
    Gatliff, Jernrna
    Ayhan, Aysel
    Nikoloudaki, Roxani
    Schaap, Marjolein
    Valko, Klara
    Javid, Farideh
    Dinkova-Kostova, Albena T.
    Kozielski, Frank
    Wells, Geoffrey
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (10) : 7380 - 7398
  • [40] Discovery of 2-oxy-2-phenylacetic acid substituted naphthalene sulfonamide derivatives as potent KEAP1-NRF2 protein-protein interaction inhibitors for inflammatory conditions
    Lu, Meng-Chen
    Shao, Hong-Li
    Liu, Tian
    You, Qi-Dong
    Jiang, Zheng-Yu
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 207
12345